BioSpace News Archive

Spinal Cord Stimulator Market: Hospitals is Anticipated to Be a Major End-user Segment of the Market

Spinal cord stimulator is also known as dorsal column stimulator. The system comprises and an electric pulse generator.

January 12, 2022
·
5 min read
West Nile Virus Infection Treatment Market | Latest Trends and Cardinal Growth Prospects

West Nile Virus infections are transmitted through mosquitoes. Birds are the major carriers of West Nile virus.

January 12, 2022
·
5 min read
Immuron Receives A$6.2 Million Award from U.S. DoD to Clinically Evaluate a Military Strength Dosing Regimen for Travelan

Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to announce the funding of a new research agreement with the U.S Department of Defense.

January 12, 2022
·
4 min read
Business

Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced plans to release its financial results for the fourth quarter and full year of 2021 on February 23, 2022 after the close of the financial markets.

January 12, 2022
·
1 min read
Biotech Beach

Agendia to Provide First Digital MammaPrint Capability to Brazil

Agendia, Inc. announced that it is offering early access to its Digital MammaPrint platform for patients with breast cancer in Brazil, expanding the company’s offerings in the country with the goal of bringing essential information from cancer testing to the larger global breast cancer community.

January 12, 2022
·
5 min read
Business

Anavasi Diagnostics Announces New Additions to Leadership Team

Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing, recently announced the addition of a Chief Financial Officer, Chief Operating Officer and Chief Commercial Officer to its management roster.

January 12, 2022
·
4 min read
BioMidwest

GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors

GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp’s OmniSeq to support the analysis and reporting of OmniSeq INSIGHT℠, a comprehensive genomic and immune profiling test for solid tumors.

January 12, 2022
·
2 min read
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000

Alar Pharmaceuticals Inc. (Alar, TWSE:6785), a clinical-stage biopharmaceutical company focused on developing long-acting injectables (LAIs) for central nervous system disorders, announces the completion and positive results of ALA-1000 SAD study (A1-19-P01).

January 12, 2022
·
3 min read
IR-Med to Announce 2022 Goals: Anticipated POC Results, File for FDA Clearance and up Listing to the OTCQB

IR-Med (OTC: IRME) (“Company” or “the Company”) is proud to announce a series of corporate updates to its investors regarding the medical, financial, and corporate status of the company.

January 12, 2022
·
4 min read
Business

CCT Research Names Jennifer Kocour President to Lead 2022 Growth Efforts

CCT Research, known for its innovative approach to conducting clinical trials, has announced Jennifer Kocour as President.

January 12, 2022
·
2 min read